Literature DB >> 7923539

A random sample survey of initial drug resistance among tuberculosis cases in Latin America.

A Laszlo1, I N de Kantor.   

Abstract

A random sample survey of initial drug resistance among cases of tuberculosis in Latin America was carried out during the second half of the 1980s and the early 1990s. A total of 948 cultures of Mycobacterium tuberculosis isolated from patients presumed never before to have been treated for tuberculosis were collected from 30 randomly selected clusters in Latin America and tested for resistance to isoniazid, streptomycin, rifampicin, ethambutol, and thioacetazone. Initial drug resistance, although unevenly distributed, was detected in all the clusters tested and characterized one out of every six tuberculosis cases. Both single and multiple resistance to streptomycin and to isoniazid were the most prevalent forms throughout the region but were not sufficiently frequent to jeopardize significantly the outcome of short-course chemotherapy. However, localized pockets of high drug resistance occurred throughout the region and are cause for concern, especially in the case of rifampicin.

Entities:  

Keywords:  Developing Countries; Diseases; Drugs; Examinations And Diagnoses; Infections; Laboratory Examinations And Diagnoses; Latin America; Research Report; Treatment; Tuberculosis

Mesh:

Substances:

Year:  1994        PMID: 7923539      PMCID: PMC2486609     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  2 in total

1.  Resistance to antituberculosis drugs in Riyadh, Saudi Arabia.

Authors:  I O al-Orainey; E S Saeed; F A el-Kassimi; N al-Shareef
Journal:  Tubercle       Date:  1989-09

2.  Advances in techniques of testing mycobacterial drug sensitivity, and the use of sensitivity tests in tuberculosis control programmes.

Authors:  G Canetti; W Fox; A Khomenko; H T Mahler; N K Menon; D A Mitchison; N Rist; N A Smelev
Journal:  Bull World Health Organ       Date:  1969       Impact factor: 9.408

  2 in total
  3 in total

1.  Screening and treatment of immigrants and refugees to Canada for tuberculosis: Implications of the experience of Canada and other industrialized countries.

Authors:  R E Thomas; B Gushulak
Journal:  Can J Infect Dis       Date:  1995-09

2.  Rapid, low-technology MIC determination with clinical Mycobacterium tuberculosis isolates by using the microplate Alamar Blue assay.

Authors:  S G Franzblau; R S Witzig; J C McLaughlin; P Torres; G Madico; A Hernandez; M T Degnan; M B Cook; V K Quenzer; R M Ferguson; R H Gilman
Journal:  J Clin Microbiol       Date:  1998-02       Impact factor: 5.948

3.  Ciprofloxacin once daily versus twice daily for the treatment of pulmonary tuberculosis.

Authors:  H Bergstermann; A Rüchardt
Journal:  Infection       Date:  1997 Jul-Aug       Impact factor: 3.553

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.